Published on
00:55 GMT
Depend on Biomakers, Not Symptoms, for Diagnosis, Early Treatment of GVHD, Experts Argue
Despite advances in transplant medicine, acute graft-versus-host disease (GVHD) remains a major threat to patient outcomes. A new review, published in the American Journal of Hematology in March 2025 explores how biomarker-driven algorithms may help …
Source:
Managed Healthcare Executive
-
Neutral
